Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Best-Performing Small-Cap Stocks of 2022

In this article, we discuss 10 best-performing small-cap stocks of 2022. If you want to see more stocks in this selection, check out 5 Best-Performing Small-Cap Stocks of 2022

O’Shaughnessy Asset Management demonstrated the relative outperformance of smaller and cheaper stocks over the long-term. The firm conducted a study measuring the annualized excess return of small-cap stocks versus large-caps in a period starting from 1964 through 2017. The results showed that smaller stocks generated an annualized excess return of 5.1% over the 54-year study, while expensive large-cap stocks generated annualized losses of 11.0%. Historical data also suggests that following extreme economic downturns, small-cap value stocks outperformed large-cap growth plays by 16.8% annualized over the next 10 years.

Small-caps benefit the most when an economy is rebounding from a slowdown. When the economy is recovering, unemployment rates rapidly go down, and businesses experience robust earnings growth, making it an ideal time to invest in small-cap stocks. Some of the biggest companies today, such as Amazon.com, Inc. (NASDAQ:AMZN), Tesla, Inc. (NASDAQ:TSLA), and Microsoft Corporation (NASDAQ:MSFT), once traded as small-caps too. The key to successful investing is buying cheap stocks with strong potential before the broader market realizes their value.

Our Methodology 

We selected the companies with market capitalization ranging from $300 million to $2 billion that have gained more than 100% year to date. The hedge fund sentiment around the securities was assessed from Insider Monkey’s Q2 2022 database of about 900 elite hedge funds. 

We have ranked the list according to the YTD share price gains, from lowest to highest. 

Image by Alexsander-777 from Pixabay

Best-Performing Small-Cap Stocks of 2022

10. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI)

Number of Hedge Fund Holders: 24

YTD Share Price Gain as of October 3: 101.54%

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) was incorporated in 2005 and is headquartered in Durham, North Carolina. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) is a pharmaceutical company engaged in the development and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) stock gained 101.54% year-to-date as of October 3, making it one of the best-performing small-cap stocks of 2022. 

On August 23, Alcon Inc. (NYSE:ALC) announced that it will acquire Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) in a deal valued at approximately $770 million. The purchase price of $15.25 per share represents a premium of 37% to Aerie Pharmaceuticals, Inc. (NASDAQ:AERI)’s last closing price. The deal is anticipated to close in the fourth quarter of 2022. This deal will solidify Alcon’s existing commercial portfolio in the $20 billion global ophthalmic pharmaceutical market.

Citi analyst Yigal Nochomovitz on August 29 downgraded Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) to Neutral from Buy with a price target of $15.25, up from $14, citing the pending acquisition by Alcon. It is “highly improbable that another bidder would emerge at this stage,” the analyst told investors in a research note.

According to Insider Monkey’s data, 24 hedge funds were bullish on Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) at the end of Q2 2022, up from 21 funds in the prior quarter. James E. Flynn’s Deerfield Management is a notable position holder in the company, with 4.70 million shares worth $35.2 million. 

Like Amazon.com, Inc. (NASDAQ:AMZN), Tesla, Inc. (NASDAQ:TSLA), and Microsoft Corporation (NASDAQ:MSFT), Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) is on the radar of elite investors. 

9. Tidewater Inc. (NYSE:TDW)

Number of Hedge Fund Holders: 16

YTD Share Price Gain as of October 3: 102.93%

Tidewater Inc. (NYSE:TDW) is a Texas-based company that provides offshore marine support and transportation services to the offshore energy sector through the operation of marine service vessels worldwide. The earnings and revenue in Q2 2022 beat Wall Street estimates, and Average Active Vessels increased from 118 to 172 on a year-over-year basis. Tidewater Inc. (NYSE:TDW) stock gained about 103% year-to-date as of October 3, which is why it made it to our list of the best-performing small-cap stocks of 2022. 

On September 6, Evercore ISI analyst James West resumed coverage of Tidewater Inc. (NYSE:TDW) with an Outperform rating and a $42 price target. Tidewater Inc. (NYSE:TDW)’s acquisition of Swire Pacific Offshore created the industry’s largest fleet of OSVs, said the analyst, who sees Tidewater as “one of the biggest beneficiaries” of the offshore oil and gas market being in the initial innings of what he anticipates to be “a long and strong upcycle.”

According to Insider Monkey’s data, 16 hedge funds were long Tidewater Inc. (NYSE:TDW) at the end of June 2022, with collective stakes worth $156.5 million, compared to 14 funds in the earlier quarter worth $148 million. Amit Wadhwaney’s Moerus Capital Management is the largest position holder in the company, with 2.4 million shares valued at $50.85 million. 

Here is what Third Avenue Management Small-Cap Value Fund has to say about Tidewater Inc. (NYSE:TDW) in its Q1 2022 investor letter:

“Within the Fund, a rapid rise in oil prices benefitted the investment in oil services company Tidewater (NYSE:TDW), which more than doubled in price last quarter. The time-arbitrage/special-situations bucket is predominantly composed of energy services company Tidewater, and other out of favor, misunderstood companies such as Hamilton Beach Brands. All of these companies are cyclical and currently out of favor, but given their strong financial positions, Fund Management believes they have the luxury of time and capital to invest and grow until the clouds dissipate.”

8. TransMedics Group, Inc. (NASDAQ:TMDX)

Number of Hedge Fund Holders: 13

YTD Share Price Gain as of October 3: 105.50%

Next on our list of the best-performing small-cap stocks of 2022 is TransMedics Group, Inc. (NASDAQ:TMDX), a Massachusetts-based commercial-stage medical technology company which specializes in organ transplant therapy for end-stage organ failure patients in the United States and internationally. TransMedics reported another solid quarterly performance in June 2022, with upside in revenue versus Wall Street estimates. TransMedics Group, Inc. (NASDAQ:TMDX) stock climbed 105.5% year-to-date as of October 3. 

On August 2, JPMorgan analyst Allen Gong upgraded TransMedics Group, Inc. (NASDAQ:TMDX) to Overweight from Neutral with a $48 price target. The company reported “another impressive beat-and-raise” in Q2 2022 as momentum across all three organs was sustained by the ongoing success of the National OCS Program, the analyst told investors in a research note. He cited TransMedics Group, Inc. (NASDAQ:TMDX)’s “highly attractive market opportunity, differentiated product offering, and above-peer growth profile” for the upgrade.

Among the hedge funds tracked by Insider Monkey, 13 funds reported owning stakes worth $60.8 million in TransMedics Group, Inc. (NASDAQ:TMDX) at the end of June 2022, up from 5 funds in the prior quarter worth $19.6 million. Richard Driehaus’ Driehaus Capital is the largest position holder in the company, with 614,881 shares worth $19.3 million. 

7. CinCor Pharma, Inc. (NASDAQ:CINC)

Number of Hedge Fund Holders: 9

YTD Share Price Gain as of October 3: 112.31%

CinCor Pharma, Inc. (NASDAQ:CINC) was incorporated in 2018 and is based in Waltham, Massachusetts. It is a clinical-stage biopharmaceutical company that develops medicines for the treatment of cardio-renal diseases. On September 28, the company announced that data from the BrigHtn trial demonstrated that its drug, baxdrostat, can potentially be paired with other agents to control high blood pressure in patients whose hypertension is refractory to treatment. As of October 3, CinCor Pharma, Inc. (NASDAQ:CINC) stock has climbed over 112% on a year-to-date basis. It is one of the best-performing small-cap stocks of 2022. 

On September 26, LifeSci Capital initiated coverage of CinCor Pharma, Inc. (NASDAQ:CINC) with an Outperform rating and a $64 price target.

According to Insider Monkey’s data, 9 hedge funds were long CinCor Pharma, Inc. (NASDAQ:CINC) at the end of the second quarter of 2022, with collective stakes worth $160 million, compared to 9 funds in the prior quarter worth $130 million. Joseph Edelman’s Perceptive Advisors is the leading stakeholder of the company, with 2.3 million shares worth $43.7 million. 

6. NexTier Oilfield Solutions Inc. (NYSE:NEX)

Number of Hedge Fund Holders: 30

YTD Share Price Gain as of October 3: 113.70%

NexTier Oilfield Solutions Inc. (NYSE:NEX) is headquartered in Houston, Texas, providing well completion and production services in multiple active and demanding basins. On August 3, NexTier Oilfield Solutions Inc. (NYSE:NEX) purchased the sand hauling, wellsite storage, and last mile logistics businesses from Continental Intermodal Group for approximately $27 million in cash and 500,000 common shares. The firm now owns all rights and interests in Sandstorm Wellsite Storage Technology as a result of this deal.

On September 26, Morgan Stanley analyst Connor Lynagh downgraded NexTier Oilfield Solutions Inc. (NYSE:NEX) to Equal Weight from Overweight with an unchanged price target of $13. The analyst favors energy services and equipment firms instead of land drillers. The North American services industry has potential to “better delineate capital returns and reinvestment frameworks to prove to the market that another cyclical capacity overbuild is not underway,” the analyst told investors in a research note. 

According to Insider Monkey’s Q2 data, 30 hedge funds were long NexTier Oilfield Solutions Inc. (NYSE:NEX), up from 28 funds in the earlier quarter. Stephen Feinberg’s Cerberus Capital Management is the largest stakeholder of the company, with 27.4 million shares worth $247.7 million. 

Investors can solidify their portfolio by looking into NexTier Oilfield Solutions Inc. (NYSE:NEX), in addition to Amazon.com, Inc. (NASDAQ:AMZN), Tesla, Inc. (NASDAQ:TSLA), and Microsoft Corporation (NASDAQ:MSFT). 

Here is what Aristotle Capital Management Small Cap Equity has to say about NexTier Oilfield Solutions Inc. (NYSE:NEX) in its Q1 2022 investor letter:

“NexTier Oilfield Solutions (NYSE:NEX), a provider of hydraulic fracturing and other completion-oriented oilfield services to exploration and production companies in the U.S., benefited from rising U.S. completion activity and rising prices due to tight supply/demand fundamentals for frac equipment. We maintain a position, as we believe the company’s dedicated service agreements, solid execution and merger synergies from recent mergers and acquisitions activity can unlock additional value for shareholders in periods to come.”

Click to continue reading and see 5 Best-Performing Small-Cap Stocks of 2022

Suggested articles:

Disclosure: None. 10 Best-Performing Small-Cap Stocks of 2022 is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 75%.

For a ridiculously low price of just $24, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

  • The Name of the Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.
  • Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
  • Lifetime Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund ANYTIME, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

  1. Head over to our website and subscribe to our Premium Readership Newsletter for just $24.
  2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.
  3. Sit back, relax, and know that you’re backed by our ironclad lifetime money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

Google CEO: This Will Be Bigger Than Electricity

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…